Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation;Erratum: Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation (Cell Metabolism (2017) 26 (394–406.e6) (S1550413117304308) (10.1016/j.cmet.2017.07.009))

Cell Metabolism

Volumn 26, Issue 3, 2017, Pages 576-

  Kim, Chai Wan ^a   Addy, Carol ^a   Kusunoki, Jun ^a   Anderson, Norma N ^a   Deja, Stanislaw ^a   Fu, Xiaorong ^a   Burgess, Shawn C ^a   Li, Cai ^a   Ruddy, Marcie ^a   Chakravarthy, Manu ^a   Previs, Steve ^a   Milstein, Stuart ^a   Fitzgerald, Kevin ^a   Kelley, David E ^a   Horton, Jay D ^a  

^a NONE

Author keywords

hepatic steatosis; acetyl CoA carboxylase; inhibitors; lipogenesis; hypertriglyceridemia; SREBPs; malonyl CoA

Indexed keywords

ACETOACETIC ACID; ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE INHIBITOR; ESSENTIAL FATTY ACID; HIGH DENSITY LIPOPROTEIN; KETONE; LOW DENSITY LIPOPROTEIN; MALONYL COENZYME A; MK 4074; PIOGLITAZONE; POLYUNSATURATED FATTY ACID; PROTEIN; PROTEIN GPAT1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; ERRATUM; FATTY ACID SYNTHESIS; FATTY LIVER; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INTERNAL MEDICINE; LIPOGENESIS; LIVER CELL; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; SINGLE DRUG DOSE; TRIACYLGLYCEROL BLOOD LEVEL; ERROR;

EID: 85028676715     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2017.07.009     Document Type: Article

References (0)